Top: Skin cells from patients with Roberts syndrome display defects in the organization of nucleoli, specialized nuclear subdomains dedicated to the production of ribosomes (shown in green). Bottom: Normal cells. DNA is shown in blue. Credit: Image: Dr. Baoshan Xu, Stowers Institute for Medical Research.
Children born with developmental disorders called cohesinopathies can suffer severe consequences, including intellectual disabilities, limb shortening, craniofacial anomalies, and slowed growth. Researchers know which mutations underlie some cohesinopathies, but have developed little understanding of the downstream signals that are disrupted in these conditions.
In a study published in the October 3, 2013, issue of PLoS Genetics, researchers at the Stowers Institute for Medical Research report that a prominent signaling pathway that drives cell growth is inhibited in the cohesinopathy known as Roberts syndrome (RBS). That work, which analyzes patient cells and zebrafish models of RBS, shows that jump-starting the sluggish signaling pathway with the amino acid L-leucine partially rescues defects associated with the disease at both the cellular and organismal level.
Cohesinopathies result from mutations in genes encoding cohesins and the factors that regulate their function. Cohesins form ring-shaped protein complexes that help organize the genome. RBS is caused by inactivation of the human gene ESCO2, which encodes an enzyme that chemically modifies cohesin.
In 2009, the team led by Stowers Investigator Jennifer Gerton, Ph.D., reported that the yeast homolog of ESCO2 plays an important role in the formation of the nucleolus, a special part of the nucleus devoted to the production of ribosomes. Ribosomes, large molecular factories made of RNA and protein, synthesize new proteins according to the instructions carried in messenger RNA.
This video is not supported by your browser at this time.
Gerton suspected that nucleolar organization might be an evolutionarily conserved function for cohesins and wondered whether cultured skin cells derived from an RBS patients would display the same nucleolar defects she had observed earlier in baker's yeast bearing a mutation in the homologous gene.
Baoshan Xu, Ph.D, a postdoctoral researcher in the Gerton lab and the current paper's first author, observed that RBS cells grew slowly and were more likely to die than normal cells. Similar to the scenario in baker's yeast, they also exhibited aberrations directly pointing to ribosome malfunction. Most importantly, mutant cells showed biochemical changes in cell growth pathways. "One was upregulation of the activity of p53, a protein that senses ribosome defects," explains Xu. "And the other was strong inhibition of mTOR, a master signaling protein that stimulates ribosome production and as a result protein synthesis."
Since the mTOR pathway can be activated with L-leucine, Xu asked whether leucine would be able to stimulate the sluggish mTOR pathway in RBS cells and ameliorate the associated cellular defects. Remarkably, L-leucine treatment "rescued" some RBS cell defects including protein synthesis and cell growth.
To examine these outcomes in a living animal, Xu then analyzed zebrafish embryos carrying inactived ESCO2. These fish exhibit several properties of human RBS, including underdeveloped cranial features and slow growth. Supplementing L-leucine stimulated the mTOR pathways in RBS zebrafish and resulted in better growth and development.
Gerton is encouraged but cautious about these findings. "Use of a non-toxic, inexpensive amino acid to treat human disease could be of benefit," she says, noting that L-leucine dietary supplementation is being tested in clinical trials for Diamond Blackfan anemia, a genetic disorder. "Leucine supplementation might improve some disease manifestations in RBS, but many aspects of RBS are unlikely to respond to post-natal leucine treatment."
RBS is a rare cohesinopathy, but a related condition called Cornelia de Lange syndrome (CdLS) occurs more frequently—about 1 in 10,000 live births. Researchers have defined mutations causing CdLS, and CdLS zebrafish models are also available. In fact, Gerton recently received a grant from the Cornelia de Lange Syndrome Foundation to assess the effect of L-leucine supplementation in those fish.
Gerton says this work serves as an example of how understanding basic biology can contribute to understanding human disease. "It was only by recognizing the nucleolar defect in baker's yeast that we suspected the involvement of the mTOR pathway and the potential benefit of L-leucine for RBS." The mTOR pathway is also affected in other human diseases, and the effect of L-leucine needs to be tested for those diseases. "Both RBS and CdLS are caused by mutations that affect cohesin, although the molecular basis of CdLS is less well understood," she says. "A logical next step is to determine whether our work on RBS has any relationship to CdLS."
Explore further: RBS says technical issues blocking mobile apps
Medical Xpress on facebook
Related Stories
RBS says technical issues blocking mobile apps
Mar 28, 2013
(AP)—British bank RBS says technical issues have prevented customers from logging into its mobile applications—another in a series of computer glitches that has hit the struggling institution.
Proteins that deliver leucine to prostate cancer cells are therapeutic targets
Sep 19, 2013
Like normal cells, cancer cells require amino acids for growth, maintenance, and cell signaling, and L-type amino acid transporters (LATs) are the delivery vehicles that supply them. Metastatic, castration-resistant prostate ...
Leucine deprivation proves deadly to malignant melanoma cells
May 16, 2011
Whitehead Institute researchers have found that depriving human melanoma cells of the essential amino acid leucine can be lethal to the cells, suggesting a possible strategy for therapeutic intervention.
Rett syndrome gene dysfunction redefined
5 hours ago
Whitehead Institute researchers have redefined the function of a gene whose mutation causes Rett syndrome, a neurodevelopmental autism spectrum disorder. This new research offers an improved understanding of the defects found ...
Mutations impair childhood growth and development by disrupting organization of chromosome pairs
May 29, 2012
Researchers studying rare genetic disorders have uncovered insights into those diseases in biological structures that regulate chromosomes when cells divide. Focusing on the cohesin complex, a group of proteins ...
Recommended for you
Sieving through 'junk' DNA reveals cancer-causing genetic mutations
3 hours ago
Researchers can now identify DNA regions within non-coding DNA, the major part of the genome that is not translated into a protein, where mutations can cause diseases such as cancer.
Method for 'designer babies' in the ethical spotlight
3 hours ago
European bioethicists raised the red flag Thursday over an American patent for a method that could allow people to choose genetic traits like eye colour in children sired from donor eggs or sperm.
Genetic analysis of individuals with autism finds gene deletions
5 hours ago
Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with ...
With population rise, natural laws purge nastiest genes
9 hours ago
(Medical Xpress)—As human population grows, disease-causing genetic mutations per individual increase, but each mutation is less harmful, when compared with a population that is not growing, says a Cornell study to be published ...
Advanced technology for gene expression analysis can facilitate drug development
9 hours ago
When developing new drugs, monitoring cellular responses to candidate compounds is essential for assessing their efficacy and safety. Researchers from the RIKEN Center for Life Science Technologies report ...
New advances in the study of human mitochondrial DNA
9 hours ago
A study concerning the evolution of mitochondrial DNA, performed by researchers from the Universitat Autònoma de Barcelona (UAB), has allowed to determine the frequency and pattern of heteroplasmy in the complete mitochondrial ...
User comments
© Medical Xpress 2011-2013, Phys.org network
Top: Skin cells from patients with Roberts syndrome display defects in the organization of nucleoli, specialized nuclear subdomains dedicated to the production of ribosomes (shown in green). Bottom: Normal cells. DNA is shown in blue. Credit: Image: Dr. Baoshan Xu, Stowers Institute for Medical Research.
Children born with developmental disorders called cohesinopathies can suffer severe consequences, including intellectual disabilities, limb shortening, craniofacial anomalies, and slowed growth. Researchers know which mutations underlie some cohesinopathies, but have developed little understanding of the downstream signals that are disrupted in these conditions.
In a study published in the October 3, 2013, issue of PLoS Genetics, researchers at the Stowers Institute for Medical Research report that a prominent signaling pathway that drives cell growth is inhibited in the cohesinopathy known as Roberts syndrome (RBS). That work, which analyzes patient cells and zebrafish models of RBS, shows that jump-starting the sluggish signaling pathway with the amino acid L-leucine partially rescues defects associated with the disease at both the cellular and organismal level.
Cohesinopathies result from mutations in genes encoding cohesins and the factors that regulate their function. Cohesins form ring-shaped protein complexes that help organize the genome. RBS is caused by inactivation of the human gene ESCO2, which encodes an enzyme that chemically modifies cohesin.
In 2009, the team led by Stowers Investigator Jennifer Gerton, Ph.D., reported that the yeast homolog of ESCO2 plays an important role in the formation of the nucleolus, a special part of the nucleus devoted to the production of ribosomes. Ribosomes, large molecular factories made of RNA and protein, synthesize new proteins according to the instructions carried in messenger RNA.
This video is not supported by your browser at this time.
Gerton suspected that nucleolar organization might be an evolutionarily conserved function for cohesins and wondered whether cultured skin cells derived from an RBS patients would display the same nucleolar defects she had observed earlier in baker's yeast bearing a mutation in the homologous gene.
Baoshan Xu, Ph.D, a postdoctoral researcher in the Gerton lab and the current paper's first author, observed that RBS cells grew slowly and were more likely to die than normal cells. Similar to the scenario in baker's yeast, they also exhibited aberrations directly pointing to ribosome malfunction. Most importantly, mutant cells showed biochemical changes in cell growth pathways. "One was upregulation of the activity of p53, a protein that senses ribosome defects," explains Xu. "And the other was strong inhibition of mTOR, a master signaling protein that stimulates ribosome production and as a result protein synthesis."
Since the mTOR pathway can be activated with L-leucine, Xu asked whether leucine would be able to stimulate the sluggish mTOR pathway in RBS cells and ameliorate the associated cellular defects. Remarkably, L-leucine treatment "rescued" some RBS cell defects including protein synthesis and cell growth.
To examine these outcomes in a living animal, Xu then analyzed zebrafish embryos carrying inactived ESCO2. These fish exhibit several properties of human RBS, including underdeveloped cranial features and slow growth. Supplementing L-leucine stimulated the mTOR pathways in RBS zebrafish and resulted in better growth and development.
Gerton is encouraged but cautious about these findings. "Use of a non-toxic, inexpensive amino acid to treat human disease could be of benefit," she says, noting that L-leucine dietary supplementation is being tested in clinical trials for Diamond Blackfan anemia, a genetic disorder. "Leucine supplementation might improve some disease manifestations in RBS, but many aspects of RBS are unlikely to respond to post-natal leucine treatment."
RBS is a rare cohesinopathy, but a related condition called Cornelia de Lange syndrome (CdLS) occurs more frequently—about 1 in 10,000 live births. Researchers have defined mutations causing CdLS, and CdLS zebrafish models are also available. In fact, Gerton recently received a grant from the Cornelia de Lange Syndrome Foundation to assess the effect of L-leucine supplementation in those fish.
Gerton says this work serves as an example of how understanding basic biology can contribute to understanding human disease. "It was only by recognizing the nucleolar defect in baker's yeast that we suspected the involvement of the mTOR pathway and the potential benefit of L-leucine for RBS." The mTOR pathway is also affected in other human diseases, and the effect of L-leucine needs to be tested for those diseases. "Both RBS and CdLS are caused by mutations that affect cohesin, although the molecular basis of CdLS is less well understood," she says. "A logical next step is to determine whether our work on RBS has any relationship to CdLS."
Explore further: RBS says technical issues blocking mobile apps
Medical Xpress on facebook
Related Stories
RBS says technical issues blocking mobile apps
Mar 28, 2013
(AP)—British bank RBS says technical issues have prevented customers from logging into its mobile applications—another in a series of computer glitches that has hit the struggling institution.
Proteins that deliver leucine to prostate cancer cells are therapeutic targets
Sep 19, 2013
Like normal cells, cancer cells require amino acids for growth, maintenance, and cell signaling, and L-type amino acid transporters (LATs) are the delivery vehicles that supply them. Metastatic, castration-resistant prostate ...
Leucine deprivation proves deadly to malignant melanoma cells
May 16, 2011
Whitehead Institute researchers have found that depriving human melanoma cells of the essential amino acid leucine can be lethal to the cells, suggesting a possible strategy for therapeutic intervention.
Rett syndrome gene dysfunction redefined
5 hours ago
Whitehead Institute researchers have redefined the function of a gene whose mutation causes Rett syndrome, a neurodevelopmental autism spectrum disorder. This new research offers an improved understanding of the defects found ...
Mutations impair childhood growth and development by disrupting organization of chromosome pairs
May 29, 2012
Researchers studying rare genetic disorders have uncovered insights into those diseases in biological structures that regulate chromosomes when cells divide. Focusing on the cohesin complex, a group of proteins ...
Recommended for you
Sieving through 'junk' DNA reveals cancer-causing genetic mutations
3 hours ago
Researchers can now identify DNA regions within non-coding DNA, the major part of the genome that is not translated into a protein, where mutations can cause diseases such as cancer.
Method for 'designer babies' in the ethical spotlight
3 hours ago
European bioethicists raised the red flag Thursday over an American patent for a method that could allow people to choose genetic traits like eye colour in children sired from donor eggs or sperm.
Genetic analysis of individuals with autism finds gene deletions
5 hours ago
Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with ...
With population rise, natural laws purge nastiest genes
9 hours ago
(Medical Xpress)—As human population grows, disease-causing genetic mutations per individual increase, but each mutation is less harmful, when compared with a population that is not growing, says a Cornell study to be published ...
Advanced technology for gene expression analysis can facilitate drug development
9 hours ago
When developing new drugs, monitoring cellular responses to candidate compounds is essential for assessing their efficacy and safety. Researchers from the RIKEN Center for Life Science Technologies report ...
New advances in the study of human mitochondrial DNA
9 hours ago
A study concerning the evolution of mitochondrial DNA, performed by researchers from the Universitat Autònoma de Barcelona (UAB), has allowed to determine the frequency and pattern of heteroplasmy in the complete mitochondrial ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment